Jakob Dupont, SVP & Chief Medical Officer at OncoMed Pharmaceuticals Inc (OMED), sold 2,500 shares at $20.13 ($50K) on 2015-07-10, disclosed to the SEC on 2015-07-13.
Scheduled sale ($50k) by SVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2022-11-18 | $19K | — | Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |